Evidence map›Paper›PMID 41683707›Full record

ReviewInternational journal of molecular sciences2026

Reconstructing the Islets: Advances in 3D Pancreatic Organoid Models for Functional β-Cell Replacement.

Muhammad Kamal Hossain, Hyung-Ryong Kim

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Muhammad Kamal HossainOrganoids Laboratory, Department of Pharmacology, College of Dentistry, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0000-0003-2132-2984
Hyung-Ryong KimOrganoids Laboratory, Department of Pharmacology, College of Dentistry, Jeonbuk National University, Jeonju 54896, Republic of Korea.ORCID 0000-0002-6710-6964

Funding

National Research Foundation of Korea 2023R1A2C2003446, RS-202300225239
6 · The paper itself

Abstract

Pancreatic β-cell replacement represents a promising therapeutic avenue for insulin-dependent diabetes, yet clinical translation has been limited by donor scarcity, immune rejection, and incomplete engraftment. Three-dimensional (3D) pancreatic organoids derived from human pluripotent stem cells (hPSCs) or primary tissue offer a scalable and physiologically relevant platform, recapitulating native islet architecture, paracrine interactions, and glucose-responsive insulin secretion. Recent advances in differentiation protocols, vascularization strategies, and immune-protective approaches-including encapsulation and hypoimmunogenic engineering-have enhanced β-cell maturation, survival, and functional performance

Indexed as

Insulin-Secreting CellsIslets of LangerhansOrganoidsTissue EngineeringAnimalsCell DifferentiationHumansModels, BiologicalPluripotent Stem Cellshypoimmunogenic engineeringimmune protectionislet architecturepancreatic organoidsvascularizationβ-cell maturationβ-cell replacement

Identifiers

PMID41683707
PMCPMC12898197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.